CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 79 filers reported holding CYTOSORBENTS CORP in Q2 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $370 | -90.8% | 197 | -82.5% | 0.00% | – |
| Q2 2023 | $4,040 | +149.7% | 1,125 | +134.4% | 0.00% | – |
| Q1 2023 | $1,618 | -70.6% | 480 | -86.5% | 0.00% | – |
| Q4 2022 | $5,496 | -21.5% | 3,546 | -37.3% | 0.00% | – |
| Q3 2022 | $7,000 | +600.0% | 5,658 | +1135.4% | 0.00% | – |
| Q2 2022 | $1,000 | -90.0% | 458 | -85.7% | 0.00% | – |
| Q1 2022 | $10,000 | -79.2% | 3,193 | -71.6% | 0.00% | – |
| Q4 2021 | $48,000 | +269.2% | 11,253 | +603.8% | 0.00% | – |
| Q3 2021 | $13,000 | -50.0% | 1,599 | -53.2% | 0.00% | – |
| Q2 2021 | $26,000 | -60.6% | 3,418 | -54.9% | 0.00% | – |
| Q1 2021 | $66,000 | +6.5% | 7,582 | -3.1% | 0.00% | – |
| Q4 2020 | $62,000 | +3000.0% | 7,823 | +2456.5% | 0.00% | – |
| Q3 2020 | $2,000 | -98.5% | 306 | -97.7% | 0.00% | – |
| Q2 2020 | $133,000 | -39.8% | 13,482 | -52.9% | 0.00% | – |
| Q1 2020 | $221,000 | +33.1% | 28,651 | -33.4% | 0.00% | – |
| Q4 2019 | $166,000 | +33.9% | 43,015 | +74.2% | 0.00% | – |
| Q3 2019 | $124,000 | -60.6% | 24,689 | -48.3% | 0.00% | – |
| Q2 2019 | $315,000 | +18.4% | 47,719 | +35.8% | 0.00% | – |
| Q1 2019 | $266,000 | +5.1% | 35,140 | +12.5% | 0.00% | – |
| Q4 2018 | $253,000 | -15.4% | 31,233 | +35.1% | 0.00% | – |
| Q3 2018 | $299,000 | -26.2% | 23,125 | -34.9% | 0.00% | – |
| Q2 2018 | $405,000 | +40400.0% | 35,511 | +36890.6% | 0.00% | – |
| Q1 2018 | $1,000 | -90.0% | 96 | -93.6% | 0.00% | – |
| Q4 2017 | $10,000 | – | 1,495 | +1490.4% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 94 | -97.6% | 0.00% | – |
| Q4 2016 | $21,000 | +425.0% | 3,900 | +505.6% | 0.00% | – |
| Q3 2016 | $4,000 | -71.4% | 644 | -79.1% | 0.00% | – |
| Q2 2016 | $14,000 | 0.0% | 3,082 | +36.6% | 0.00% | – |
| Q3 2015 | $14,000 | -22.2% | 2,256 | -25.0% | 0.00% | – |
| Q2 2015 | $18,000 | -33.3% | 3,009 | +49.4% | 0.00% | – |
| Q1 2015 | $27,000 | – | 2,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |